During the past decade, Diabetologicka a obezitologicka ambulance conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetologicka a obezitologicka ambulance" #1 collaborator was "Nordic Bioscience A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Diabetologicka a obezitologicka ambulance" are "Type 2 Diabetes Mellitus" (2 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Diabetologicka a obezitologicka ambulance" in a lesser frequency.

Most popular intervention types in "Diabetologicka a obezitologicka ambulance" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (2 trials), "Daily injection of KBP/placebo for 12 weeks as add-on to metformin" (1 trials), "Dulaglutide" (1 trials), "Insulin Glargine (U100)" (1 trials) and "Insulin Lispro (U100)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetologicka a obezitologicka ambulance" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Diabetologicka a obezitologicka ambulance". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Diabetologicka a obezitologicka ambulance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diabetologicka a obezitologicka ambulance, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".